Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru

dc.date.accessioned2019-02-06T14:57:42Z
dc.date.available2019-02-06T14:57:42Z
dc.date.created2019-02-06T14:57:42Z
dc.date.issued2015
dc.identifierhttps://hdl.handle.net/20.500.12866/5499
dc.identifierhttps://doi.org/10.1111/tmi.12430
dc.description.abstractOBJECTIVE: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. METHODS: We studied new smear-positive TB adults that were started on MDR TB treatment or that were switched to it between June 2008 and December 2011. RESULTS: Time from the first positive smear to MDR-TB treatment was >30 days in 35% (13/37) of patients. Among the 27% (24/88) of patients that switched to MDR-TB treatment, time from the last dose of a drug-susceptible regimen was >30 days. CONCLUSION: Start of and switching to MDR TB treatment is still delayed.
dc.languageeng
dc.publisherWiley
dc.relationTropical Medicine and International Health
dc.relation1365-3156
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectPeru
dc.subjectAdult
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectRetrospective Studies
dc.subjectTuberculosis
dc.subjectTime Factors
dc.subjectPeru/epidemiology
dc.subjecttuberculosis
dc.subjecttuberculose
dc.subjectOutcome Assessment (Health Care)
dc.subjectIncidence
dc.subjectAntitubercular Agents/therapeutic use
dc.subjectDrug Substitution/statistics & numerical data
dc.subjectmultidrug resistant
dc.subjectmultiresistante
dc.subjectmultirresistente
dc.subjectPerou
dc.subjecttemps jusqu'au traitement
dc.subjectTiempo hasta el inicio del tratamiento
dc.subjecttime to treatment
dc.subjectTuberculosis, Multidrug-Resistant/drug therapy/epidemiology
dc.subjectTuberculosis, Pulmonary/drug therapy/epidemiology
dc.titleTime to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución